Genfit Assesses Optimal Elafibranor NASH Combo Therapy Opportunity

 
• By Joseph Haas
  
Old buildings on the Grand Place square at the evening, Lille, France - Image
Based in Lille, France, Genfit is one of five companies to reach Phase III in NASH
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business